ASCO’s recent release of resource-stratified guidelines for the prevention and treatment of invasive cervical cancer has provided valuable guidance to low- and middle- income countries (LMICs), where approximately 85% of cervical cancer cases occur.
After two recent clinical trials provided long-awaited new information on the role of lymph node management in patients with melanoma, a panel was formed to update the 2012 ASCO-Society of Surgical Oncology (SSO) guidelines for sentinel lymph node (SLN) biopsy.
Mortality-extending strategies in the management of head and neck neoplasms are critically important—but preservation of the larynx is also highly desirable, as maintaining a functioning voice and swallowing conduit is vital to a patient’s quality of life.
Gabriel N. Hortobagyi, MD, FACP, FASCO, is the recipient of the 2018 Gianni Bonadonna Breast Cancer Award for his leadership and contribution in the field of translational medicine in breast cancer, with an exceptional record of mentorship.
Supriya G. Mohile, MD, MS, associate professor of medicine at the James Wilmot Cancer Center at the University of Rochester, is the recipient of the 2018 B.J. Kennedy Award for Scientific Excellence in Geriatric Oncology.
Data presented during the 2012 ASCO Annual Meeting demonstrated the potential of anti–PD-1 and anti–PD-L1 therapy for multiple cancers and introduced groundbreaking change in oncology research and treatment.
Gallbladder cancer (GBC) is rare in Europe, the United States, and Canada. However, in some areas of South America, particularly in the Andean region of Chile, Ecuador, Peru, and Bolivia, the incidence and mortality rate are high.